Berthold A Nock (Beatrice Waser)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Topics

Positron Emission Tomography

Prostate Cancer

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Aikaterini Tatsi, Theodosia Maina, Beatrice Waser, Eric P Krenning, Marion de Jong, Jean Claude Reubi, Paul Cordopatis, Berthold A Nock
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile. International journal of molecular sciences 25 (3) (2024)
Aikaterini Tatsi, Theodosia Maina, Beatrice Waser, Eric P Krenning, Marion de Jong, Jean Claude Reubi, Paul Cordopatis, Berthold A Nock
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile. International journal of molecular sciences 25 (3) (2024)
Aikaterini Tatsi, Theodosia Maina, Beatrice Waser, Eric P Krenning, Marion de Jong, Jean Claude Reubi, Paul Cordopatis, Berthold A Nock
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile. International journal of molecular sciences 25 (3) (2024)
Xabier Guarrochena, Panagiotis Kanellopoulos, Anna Stingeder, Lisa-Maria Rečnik, Irene V J Feiner, Marie R Brandt, Wolfgang Kandioller, Theodosia Maina, Berthold A Nock, Thomas L Mindt
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability. Pharmaceutics 16 (3) (2024)
Karim Obeid, Panagiotis Kanellopoulos, Ayman Abouzayed, Adam Mattsson, Vladimir Tolmachev, Berthold A Nock, Theodosia Maina, Anna Orlova
GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics. Pharmaceutics 16 (4) (2024)
Aikaterini Tatsi, Theodosia Maina, Beatrice Waser, Eric P Krenning, Marion de Jong, Jean Claude Reubi, Paul Cordopatis, Berthold A Nock
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile. International journal of molecular sciences 25 (3) (2024)
Xabier Guarrochena, Panagiotis Kanellopoulos, Anna Stingeder, Lisa-Maria Rečnik, Irene V J Feiner, Marie R Brandt, Wolfgang Kandioller, Theodosia Maina, Berthold A Nock, Thomas L Mindt
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability. Pharmaceutics 16 (3) (2024)
Karim Obeid, Panagiotis Kanellopoulos, Ayman Abouzayed, Adam Mattsson, Vladimir Tolmachev, Berthold A Nock, Theodosia Maina, Anna Orlova
GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics. Pharmaceutics 16 (4) (2024)
Aikaterini Tatsi, Theodosia Maina, Beatrice Waser, Eric P Krenning, Marion de Jong, Jean Claude Reubi, Paul Cordopatis, Berthold A Nock
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile. International journal of molecular sciences 25 (3) (2024)
Aikaterini Tatsi, Theodosia Maina, Beatrice Waser, Eric P Krenning, Marion de Jong, Jean Claude Reubi, Paul Cordopatis, Berthold A Nock
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile. International journal of molecular sciences 25 (3) (2024)
Xabier Guarrochena, Panagiotis Kanellopoulos, Anna Stingeder, Lisa-Maria Rečnik, Irene V J Feiner, Marie R Brandt, Wolfgang Kandioller, Theodosia Maina, Berthold A Nock, Thomas L Mindt
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability. Pharmaceutics 16 (3) (2024)
Panagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, Theodosia Maina
Toward Stability Enhancement of NTS 1 R-Targeted Radioligands: Structural Interventions on [ 99m Tc]Tc-DT1. Pharmaceutics 15 (8) (2023)
Berthold A Nock, Panagiotis Kanellopoulos, Lieke Joosten, Rosalba Mansi, Theodosia Maina
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Panagiotis Kanellopoulos, Berthold A Nock, Maritina Rouchota, George Loudos, Eric P Krenning, Theodosia Maina
Side-Chain Modified [ 99m Tc]Tc-DT1 Mimics: A Comparative Study in NTS 1 R-Positive Models. International journal of molecular sciences 24 (21) (2023)
Berthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, Maritina Rouchota, George Loudos, Sanjana Ballal, Madhav P Yadav, Chandrasekhar Bal, Prashant Mishra, Parvind Sheokand, Frank Roesch, Theodosia Maina
[ 111 In]In/[ 177 Lu]Lu-AAZTA 5 -LM4 SST 2 R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results. Pharmaceutics 15 (3) (2023)
Berthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, Maritina Rouchota, George Loudos, Sanjana Ballal, Madhav P Yadav, Chandrasekhar Bal, Prashant Mishra, Parvind Sheokand, Frank Roesch, Theodosia Maina
[ 111 In]In/[ 177 Lu]Lu-AAZTA 5 -LM4 SST 2 R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results. Pharmaceutics 15 (3) (2023)
Ayman Abouzayed, Panagiotis Kanellopoulos, Alisa Gorislav, Vladimir Tolmachev, Theodosia Maina, Berthold A Nock, Anna Orlova
Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics. Biomolecules 13 (7) (2023)
Berthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, Maritina Rouchota, George Loudos, Sanjana Ballal, Madhav P Yadav, Chandrasekhar Bal, Prashant Mishra, Parvind Sheokand, Frank Roesch, Theodosia Maina
[ 111 In]In/[ 177 Lu]Lu-AAZTA 5 -LM4 SST 2 R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results. Pharmaceutics 15 (3) (2023)
Panagiotis Kanellopoulos, Berthold A Nock, Lukas Greifenstein, Richard P Baum, Frank Roesch, Theodosia Maina
[ 68 Ga]Ga-DATA 5m -LM4, a PET Radiotracer in the Diagnosis of SST 2 R-Positive Tumors: Preclinical and First Clinical Results. International journal of molecular sciences 23 (23) (2022)
Panagiotis Kanellopoulos, Berthold A Nock, Lukas Greifenstein, Richard P Baum, Frank Roesch, Theodosia Maina
[ 68 Ga]Ga-DATA 5m -LM4, a PET Radiotracer in the Diagnosis of SST 2 R-Positive Tumors: Preclinical and First Clinical Results. International journal of molecular sciences 23 (23) (2022)
Panagiotis Kanellopoulos, Berthold A Nock, Lukas Greifenstein, Richard P Baum, Frank Roesch, Theodosia Maina
[ 68 Ga]Ga-DATA 5m -LM4, a PET Radiotracer in the Diagnosis of SST 2 R-Positive Tumors: Preclinical and First Clinical Results. International journal of molecular sciences 23 (23) (2022)
Berthold A Nock, Panagiotis Kanellopoulos, Oleg G Chepurny, Maritina Rouchota, George Loudos, George G Holz, Eric P Krenning, Theodosia Maina
Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK 2 R Cancer Theranostic Agents: A Preclinical Study. Pharmaceutics 14 (3) (2022)
Panagiotis Kanellopoulos, Berthold A Nock, Lukas Greifenstein, Richard P Baum, Frank Roesch, Theodosia Maina
[ 68 Ga]Ga-DATA 5m -LM4, a PET Radiotracer in the Diagnosis of SST 2 R-Positive Tumors: Preclinical and First Clinical Results. International journal of molecular sciences 23 (23) (2022)
Rosalba Mansi, Berthold A Nock, Simone U Dalm, Martijn B Busstra, Thomas A Kirkland, Theodosia Maina
Radiolabeled Bombesin Analogs. Cancers 13 (22) (2021)
Berthold A Nock, Aikaterini Kaloudi, Panagiotis Kanellopoulos, Barbara Janota, Barbara Bromińska, Dariusz Iżycki, Renata Mikolajczak, Rafał Czepczyński, Theodosia Maina
[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes. Cancers 13 (20) (2021)
Panagiotis Kanellopoulos, Emmanouil Lymperis, Aikaterini Kaloudi, Marion de Jong, Eric P Krenning, Berthold A Nock, Theodosia Maina
[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models. Molecules (Basel, Switzerland) 25 (15) (2020)
Panagiotis Kanellopoulos, Aikaterini Kaloudi, Maritina Rouchota, George Loudos, Marion de Jong, Eric P Krenning, Berthold A Nock, Theodosia Maina
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [99mTc]Tc-DB4 and [111In]In-SG4 in Mice Treated with Entresto. Pharmaceutics 12 (12) (2020)
Panagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, Theodosia Maina
Optimizing the Profile of [99mTc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors. International journal of molecular sciences 21 (21) (2020)
Berthold A Nock, Theodosia Maina
Theranostic approaches in nuclear oncology: From bench to bed. Journal of labelled compounds & radiopharmaceuticals 62 (10) (2020)
Panagiotis Kanellopoulos, Aikaterini Kaloudi, Marion de Jong, Eric P Krenning, Berthold A Nock, Theodosia Maina
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands. Pharmaceutics 12 (6) (2020)
Aikaterini Kaloudi, Emmanouil Lymperis, Panagiotis Kanellopoulos, Berthold A Nock, Marion de Jong, Eric P Krenning, Jean Claude Reubi, Theodosia Maina
Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses. Pharmaceuticals (Basel, Switzerland) 12 (1) (2019)
Emmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos, Eric P Krenning, Marion de Jong, Theodosia Maina, Berthold A Nock
Comparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stability. Journal of labelled compounds & radiopharmaceuticals 62 (10) (2019)
Jean-Philippe Sinnes, Johannes Nagel, Bradley P Waldron, Theodosia Maina, Berthold A Nock, Ralf K Bergmann, Martin Ullrich, Jens Pietzsch, Michael Bachmann, Richard P Baum, Frank Rösch
Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC. EJNMMI research 9 (1) (2019)
Emmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos, Marion de Jong, Eric P Krenning, Berthold A Nock, Theodosia Maina
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair. Molecules (Basel, Switzerland) 24 (6) (2019)
Aikaterini Kaloudi, Emmanouil Lymperis, Athina Giarika, Simone Dalm, Francesca Orlandi, Donato Barbato, Mattia Tedesco, Theodosia Maina, Marion de Jong, Berthold A Nock
NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice. Molecules (Basel, Switzerland) 22 (11) (2017)